Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Pfizer

Ian Read, Pfizer’s new chief executive officer, has made changes to the company’s executive team.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ian Read, Pfizer’s new chief executive officer, has made changes to the company’s executive team. Mr. Read elevated his executive team to take over the responsibilities of his former position, overseeing the sales and marketing of certain prescription drug units. The team includes longtime employees Olivier Brandicourt and David Simmons. Mr. Brandicourt runs Pfizer’s prescription drugs business. Mr. Simmons was instrumental in the company’s expansion into emerging markets, such as China, aimed at increasing revenue.

R&D chief Mikael Dolsten, who came over from Wyeth, will remain in his position. Geno Germano, also from Wyeth, will join the company’s executive leadership team. He runs the business that sells oncology products and other medicines.

Chief financial officer Frank D’Amelio was also given control of manufacturing. Tony Maddaluna will be head of global manufacturing, reporting to Mr. D’Amelio. The unit was previously run by Nat Ricciardi, who is retiring in 2011 after 38 years with Pfizer.

Cavan Redmond will have expanded responsibilities. He currently runs Pfizer’s consumer and animal-health businesses. Mary McLeod, the head of human resources, is leaving the company. Chuck Hill, who had been running human resources for Mr. Read’s pharmaceutical sales and marketing operations, will succeed Ms. McLeod. Additionally, George Lorch has been elected as a new chairman of the board, succeeding Mr. Jeff Kindler, Pfizer’s previous chief executive officer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters